EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a ...

Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.

Georgia Urology is bringing a new prostate cancer treatment to the Northeast Georgia region. NanoKnife, the AngioDynamics system recognized by TIME as one of its Best Inventions of 2025, is a ...

A new procedure for prostate cancer biopsies is now being offered at Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center.

A new, pioneering procedure was used to treat a record number of prostate patients in a day. Frimley Health NHS Foundation trust were able to break their record thanks to the use of a robot-assisted ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

NEWTOWN, Conn., March 31, 2026 /PRNewswire/ -- Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain bladder control after prostate ...

A joystick-like robot lets Emory doctors guide a tiny wire to blocked blood vessels, offering precise, minimally invasive ...

Mar 27, 2026, 7:45 AM ETProfound Medical Corp. (PROF), PRN:CA The TULSA Procedure, performed using the TULSA-PRO ® system, represents a major advancement in prostate care, and is used by physicians to ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...